-
公开(公告)号:US10072282B2
公开(公告)日:2018-09-11
申请号:US15002790
申请日:2016-01-21
Applicant: Cornell University
Inventor: Hening Lin
IPC: G01N33/68 , C12Q1/34 , C07C225/06 , A61K31/12 , A61K31/131 , G01N33/15 , C12Q1/48 , C07C327/42 , C07K7/06 , C07K5/11
CPC classification number: C12Q1/48 , C07C327/42 , C07K5/1019 , C07K7/06 , C12Q1/34 , G01N2333/91091 , G01N2333/98 , G01N2500/04 , G01N2500/20
Abstract: Method for identifying a modulator of Sirt6, PfSir2a, or Sirt7 deacylase activity, wherein a fatty-acylated substrate containing an acyl-lysine moiety and an indicator moiety is contacted with Sirt6, PfSir2a, or Sirt7 in the presence of a candidate compound under conditions for Sirt6, PfSir2a, or Sirt7 to deacylate the substrate, wherein the acyl is a hydrophobic fatty acyl group containing a hydrocarbon group having at least three carbon atoms connected by carbon-carbon bonds; contacting the deacylated substrate with a cleavage agent that cleaves the linkage between the lysine and indicator moiety to generate a detectable signal; and correlating a quantified Sirt6, PfSir2a, or Sirt7 deacylase activity therefrom. Modulating compounds of Sirt6, PfSir2a, or Sirt7 deacylase activity are also described, as are pharmaceutical compositions thereof, methods of treatment by administration of the modulating compounds, and kits for practicing the method.
-
公开(公告)号:US20160279091A1
公开(公告)日:2016-09-29
申请号:US15172756
申请日:2016-06-03
Applicant: CORNELL UNIVERSITY
Inventor: Hening Lin , Bin HE
IPC: A61K31/27
CPC classification number: A61K31/27 , A61K31/16 , C07C327/42
Abstract: The instant application describes novel compounds that modulate (in particular, inhibit) Sirt2, with structures according to Formulas (1) and (2) provided herein. The invention is also directed to pharmaceutical compositions thereof, methods of treatment (i.e., cancer and neurodegenerative disease) by administration of the modulating compounds, assay methods for finding modulators of Sirt2, and kits for practicing the assay method.
Abstract translation: 本申请描述了使用本文提供的根据式(1)和(2)的结构调节(特别是抑制)Sirt2的新型化合物。 本发明还涉及其药物组合物,通过施用调节化合物的治疗方法(即癌症和神经变性疾病),用于发现Sirt2调节剂的测定方法和用于实施测定方法的试剂盒。
-
公开(公告)号:US11110107B2
公开(公告)日:2021-09-07
申请号:US16414912
申请日:2019-05-17
Applicant: Cornell University
Inventor: Hening Lin
IPC: A61K31/7016 , A61K31/198 , C07K14/47 , A61K31/7088 , A61K38/17 , A61K31/713 , C07K7/06 , C12N15/113 , A61K31/702 , A61K38/02 , A61K38/03 , A61K38/00
Abstract: This disclosure demonstrates that inhibition of Sirt5 can suppress malignant transformation of cells. Therefore, methods of treating cancer based on inhibition of Sirt5 are disclosed.
-
公开(公告)号:US20190298747A1
公开(公告)日:2019-10-03
申请号:US16414912
申请日:2019-05-17
Applicant: Cornell University
Inventor: Hening Lin , Richard Cerione
IPC: A61K31/7016 , A61K38/17 , A61K38/03 , A61K38/02 , A61K31/702 , C07K7/06 , A61K31/7088 , C07K14/47 , C12N15/113 , A61K31/713 , A61K31/198
Abstract: This disclosure demonstrates that inhibition of Sirt5 can suppress malignant transformation of cells. Therefore, methods of treating cancer based on inhibition of Sirt5 are disclosed.
-
公开(公告)号:US09926340B2
公开(公告)日:2018-03-27
申请号:US15088561
申请日:2016-04-01
Applicant: The Board of Regents of the University of Texas System , Biolog Life Science Institute Forschungslabor und Biochemica-Vertrieb GmbH , Cornell University
Inventor: W. Lee Kraus , Bryan A. Gibson , Frank Schwede , Hening Lin
IPC: G01N33/573 , C07H21/02 , C12Q1/48
CPC classification number: C07H21/02 , C12Q1/48 , G01N2333/91142 , G01N2440/40 , G01N2458/00
Abstract: The present disclosure provides NAD analogs of the formula: wherein R1, n, and X1 are defined herein, useful for the identification of PARP target proteins and the amino acid sequence wherein the ribose group is attached to the target protein. Also, provided herein are methods of identifying target protein and amino acid sequences. Additionally, the present disclosure provides methods of identifying DNA sequences associated with specific chromatin proteins.
-
公开(公告)号:US09359293B2
公开(公告)日:2016-06-07
申请号:US14349140
申请日:2012-10-05
Applicant: CORNELL UNIVERSITY
Inventor: Hening Lin , Bin He
IPC: C07C327/42 , A61K31/16
CPC classification number: A61K31/27 , A61K31/16 , C07C327/42
Abstract: The instant application describes novel compounds that modulate (in particular, inhibit) Sirt2 , with structures according to Formulas (1) and (2) provided herein. The invention is also directed to pharmaceutical compositions thereof, methods of treatment (i.e., cancer and neurodegenerative disease) by administration of the modulating compounds, assay methods for finding modulators of Sirt2 , and kits for practicing the assay method.
Abstract translation: 本申请描述了使用本文提供的根据式(1)和(2)的结构调节(特别是抑制)Sirt2的新型化合物。 本发明还涉及其药物组合物,通过施用调节化合物的治疗方法(即癌症和神经变性疾病),用于发现Sirt2调节剂的测定方法和用于实施测定方法的试剂盒。
-
公开(公告)号:US20250092067A1
公开(公告)日:2025-03-20
申请号:US18562243
申请日:2022-05-19
Applicant: Cornell University
Inventor: Hening Lin , Kevin Wielenberg , Min Yang
IPC: C07F5/02 , A61K31/496 , A61K31/675 , A61K31/69 , C07D409/06 , C07D495/04 , C07F9/6509 , C07F9/6558
Abstract: Compounds, compositions including one or more of the compound(s), and methods of using the compounds and the compositions. The compounds comprise an (I) group. In various examples, a compound is an Acyl Protein Thioesterase 1 inhibitor (APT1 inhibitor) and/or an Acyl Protein Thioesterase 2 inhibitor (APT2 inhibitor). Compound(s) or composition(s), which may be pharmaceutical composition(s), can be used in methods of treating diseases or disorders, such as, for example, autoimmune disorders, neurodegenerative disorders, inflammatory disorders, and immune-mediated cancer diseases.
-
公开(公告)号:US20220403443A1
公开(公告)日:2022-12-22
申请号:US17840140
申请日:2022-06-14
Applicant: CORNELL UNIVERSITY
Inventor: Hening Lin , Maurine E. Linder , Jun Young Hong
IPC: C12Q1/48
Abstract: A method for determining activity of an acyl transferase enzyme, the method comprising: (i) preparing a reaction mixture comprising: (a) an acyl transferase enzyme, (b) a peptide substrate bound to a fluorophore, wherein the substrate is a cysteine-containing oligopeptide of 5-25 amino acids in length, (c) an acyl-CoA, and (d) a detergent comprising micelles, wherein the acyl transferase enzyme mediates acylation on a cysteine of said peptide substrate to result in association of the peptide with micelles of the detergent with resultant increase in fluorescence polarization; and (ii) measuring fluorescent signal of the reaction mixture; wherein an increase in fluorescence polarization of the reaction mixture compared to fluorescence polarization of a control reaction indicates acyl transferase activity of the acyl transferase enzyme. The above assay method may also be used for screening compounds for their ability to act as inhibitors of an acyl transferase enzyme.
-
公开(公告)号:US10556878B2
公开(公告)日:2020-02-11
申请号:US14896057
申请日:2014-06-06
Applicant: CORNELL UNIVERSITY
Inventor: Hening Lin
IPC: C07D335/06 , C07C335/08
Abstract: A compound useful as a Sirt2 or Sirt5 inhibitor having the formula (1) wherein: R1 is a hydrocarbon group having at least two carbon atoms connected by carbon-carbon bonds, wherein said hydrocarbon group is optionally endcapped by a neutral or anionic oxygen-containing group; R2a, R2b, and R2c are independently selected from hydrogen atom and hydrocarbon groups; X0, X1, X2, and X3 are independently selected from —(CH2)n—, —NR5—, —O—, —S—, and a bond, wherein n represents 1, 2, or 3, provided that at least one of X0-X3 is —(CH2)n—; and R3 and R4 are independently selected from the group consisting of hydrogen atom, hydrocarbon groups, biological groups, and protecting groups. Also described are pharmaceutical compositions of the inhibiting compounds, and methods of treatment by administration of the inhibiting compounds.
-
公开(公告)号:US09572789B2
公开(公告)日:2017-02-21
申请号:US15172756
申请日:2016-06-03
Applicant: CORNELL UNIVERSITY
Inventor: Hening Lin , Bin He
IPC: A61K31/27
CPC classification number: A61K31/27 , A61K31/16 , C07C327/42
Abstract: The instant application describes novel compounds that modulate (in particular, inhibit) Sirt2, with structures according to Formulas (1) and (2) provided herein. The invention is also directed to pharmaceutical compositions thereof, methods of treatment (i.e., cancer and neurodegenerative disease) by administration of the modulating compounds, assay methods for finding modulators of Sirt2, and kits for practicing the assay method.
Abstract translation: 本申请描述了使用本文提供的根据式(1)和(2)的结构调节(特别是抑制)Sirt2的新型化合物。 本发明还涉及其药物组合物,通过施用调节化合物的治疗方法(即癌症和神经变性疾病),用于发现Sirt2调节剂的测定方法和用于实施测定方法的试剂盒。
-
-
-
-
-
-
-
-
-